Ontruzant Patient assistance program
Complete a free online enrollment application to find out if you’re eligible to pay only $49 per month for your Ontruzant medication with our help.Get Started Now
Secure: Your personal and medical information is safe with us
Convenient: Your medication is delivered straight to your door
Ongoing refills: Your medication is refilled automatically
NiceRx works with your healthcare provider to help you access affordable medications directly from U.S. pharmaceutical companies.
How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are qualified. The pharmaceutical company provides your medication for free and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address.
Your monthly Ontruzant cost savings if eligible
With our assistance, you could access the Ontruzant patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Ontruzant patient assistance?
We review each Ontruzant enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Ontruzant patient assistance program?
Our process makes it as easy as possible to apply for the Ontruzant patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Ontruzant, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx an Ontruzant coupon provider?
NiceRx is not an Ontruzant coupon, Ontruzant discount card, or Ontruzant copay card provider. We do not offer Ontruzant manufacturer coupons, Ontruzant discounts, rebates, Ontruzant savings cards, trial offers, or free Ontruzant samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me get Ontruzant cheaper if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Ontruzant
- Your insurance company will not pay for your Ontruzant prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Ontruzant cost without insurance?
Without insurance, Ontruzant costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Ontruzant intravenous powder for injection dttb 150 mg will cost around $1,400 for 1 powder for injection.
How much does Ontruzant cost with insurance?
The copay for Ontruzant will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Ontruzant?
Ontruzant is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Samsung Bioepis Co., Ltd. Ontruzant is biosimilar to Herceptin (trastuzumab), meaning that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences between the biosimilar product and the reference product. Biosimilarity of Ontruzant has been demonstrated for the condition(s) of use (e.g. indication(s), dosing regimen(s)), strength(s), dosage form(s), and route(s) of administration described in its Full Prescribing Information.
Ontruzant is indicated for adjuvant treatment of HER2 overexpressing node positive or node negative (ER/PR negative or with one high risk feature) breast cancer as part of a treatment regimen consisting of doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel, as part of a treatment regimen with docetaxel and carboplatin, as a single agent following multi-modality anthracycline based therapy, in combination with cisplatin and capecitabine or 5-fluorouracil, for the treatment of HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma who have not received prior treatment for metastatic disease.
Trastuzumab can result in subclinical and clinical cardiac failure manifesting as CHF, and decreased LVEF, with the greatest risk when administered with anthracyclines. Evaluate cardiac function prior to and during treatment. Discontinue Ontruzant for cardiomyopathy, infusion reactions, pulmonary toxicity, anaphylaxis, angioedema, interstitial pneumonitis, or acute respiratory distress syndrome.
What doses of Ontruzant are available?
Ontruzant is available in injection form, in the following doses: 150 mg lyophilized powder in a single-dose vial for reconstitution.
Please read the full prescribing information and always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Ontruzant active ingredients
Ontruzant contains the active ingredient trastuzumab, which is a monoclonal antibody. Trastuzumab is designed to bind selectively to an antigen called human epidermal growth factor receptor 2 (HER2), found in large amounts on the surface of some cancer cells where it stimulates their growth. When Ontruzant binds to HER2 it stops the growth of these cells causing them to die.
Ontruzant side effects
The most common side effects of Ontruzant in clinical trials include:
- Adjuvant breast cancer – headache, diarrhea, nausea, and chills
- Metastatic breast cancer – fever, chills, headache, infection, congestive heart failure, insomnia, cough, and rash
- Metastatic gastric cancer – neutropenia, diarrhea, fatigue, anemia, stomatitis, weight loss, upper respiratory tract infections, fever, thrombocytopenia, mucosal inflammation, nasopharyngitis, and dysgeusia
In rare instances, Ontruzant can cause more serious side effects. These can include:
- Exacerbation of chemotherapy-induced neutropenia
- Left ventricular cardiac dysfunction, arrhythmias, hypertension, disabling cardiac failure, cardiomyopathy, and cardiac death
Your doctor will assess the benefits of using Ontruzant against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Ontruzant to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Ontruzant drug interactions
Other drugs may interact with Ontruzant, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medicines including any supplements you are taking.
You should not use Ontruzant if you:
- Are allergic to the active ingredient trastuzumab-dttb
- Are allergic to any of the other ingredients in Ontruzant
- Are pregnant or are planning to become pregnant – pregnant women and females of reproductive potential should avoid exposure to Ontruzant during pregnancy or within 7 months before conception, due to embryo fetal toxicity
Talk to your doctor before using Ontruzant if you:
- Are taking any of the medications that could interact with Ontruzant
- Have heart problems or high blood pressure (hypertension)
- Have congestive heart failure
- Have had a heart attack
- Have any breathing problems or other allergies
- Are breastfeeding or are planning to breastfeed
Ontruzant is the trademark brand name for trastuzumab-dttb manufactured by Samsung Bioepis Co., Ltd. A generic version of trastuzumab-dttb is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Ontruzant savings through NiceRx.
*Qualifying persons may obtain medications directly from patient assistance programs without any out-of-pocket cost (or for less than $49 per medication). However, our monthly flat rate of just $49 per medication spares you the hassle of tracking the different programs and filling out all the required paperwork for each program. Subject to medication availability.
Enrollees enjoy a full-service solution, as NiceRx assists them and their physicians with the entire process. We prepare all required documents for the physician to sign, help enrollees manage all prescription refills, monitor eligibility criteria, and maintain enrollment.
**If you do not receive medications because you were determined to be ineligible for the prescription assistance by the applicable pharmaceutical companies and you have a letter of denial, we will refund any fees you paid toward medications for which you did not qualify to receive prescription assistance (“Refund”).
To receive a refund, you must send the letter of denial to us by fax to 888-517-7444, or by e-mail to [email protected] within 30 days of your receipt of such letter. The Refund is your sole and exclusive remedy for any fees you may wish to dispute.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.